Holen Sie sich die Stockscreener-App
26.90
0.55%
-0.15
Handel nachbörslich:
26.91
0.01
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt PHG?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$27.05
Offen:
$27.36
24-Stunden-Volumen:
819.17K
Relative Volume:
1.09
Marktkapitalisierung:
$25.58B
Einnahmen:
$19.49B
Nettoeinkommen (Verlust:
$-909.25M
KGV:
-32.95
EPS:
-0.8164
Netto-Cashflow:
$966.68M
1W Leistung:
-5.01%
1M Leistung:
-4.51%
6M Leistung:
+14.66%
1J Leistung:
+2.63%
1-Tages-Spanne:
$26.83
$27.39
1-Wochen-Bereich:
$26.30
$28.32
52-Wochen-Spanne:
$21.48
$29.54
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Firmenname
Koninklijke Philips N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips N V Adr
|
26.90 | 25.72B | 19.49B | -909.25M | 966.68M | -0.8164 |
|
ABT
Abbott Laboratories
|
122.09 | 217.50B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
93.84 | 144.57B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.60 | 139.21B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.26 | 129.94B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.32 | 50.02B | 5.88B | 1.34B | 799.60M | 2.3489 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-10-29 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-05-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Hochstufung | UBS | Sell → Neutral |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-01-17 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-09-06 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-06-16 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-14 | Hochstufung | HSBC Securities | Hold → Buy |
| 2022-01-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-08 | Eingeleitet | Jefferies | Buy |
| 2021-07-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-03-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Eingeleitet | Societe Generale | Buy |
| 2019-07-30 | Eingeleitet | Citigroup | Buy |
| 2018-02-12 | Hochstufung | Berenberg | Hold → Buy |
| 2017-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Herabstufung | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2016-12-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Eingeleitet | Citigroup | Buy |
| 2016-05-11 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2015-11-27 | Eingeleitet | ING Group | Hold |
| 2015-09-08 | Eingeleitet | Credit Suisse | Outperform |
| 2015-08-27 | Hochstufung | Nomura | Neutral → Buy |
| 2015-07-28 | Hochstufung | Societe Generale | Hold → Buy |
| 2011-01-25 | Herabstufung | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Hochstufung | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Herabstufung | UBS | Buy → Neutral |
Alle ansehen
Koninklijke Philips N V Adr Aktie (PHG) Neueste Nachrichten
AI-Powered Remote Electrocardiogram (ECG) Monitoring Market Report 2025 - GlobeNewswire Inc.
Koninklijke Philips N.V. (PHG): A Bull Case Theory - Finviz
Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy - GlobeNewswire Inc.
Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy - Sahm
Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform - Finviz
Philips launches Verida, world's first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision - Finviz
Creative Planning Has $1.38 Million Stock Position in Koninklijke Philips N.V. $PHG - Defense World
Artificial Intelligence in Remote Patient Monitoring Market Projected to Reach $14.51 Billion by 2032, Growing at a CAGR of 27.52% - GlobeNewswire Inc.
Sony Group Corp. ADR falls Tuesday, underperforms market - MarketWatch
Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere - Finviz
Sony Group Corp. ADR outperforms market on strong trading day - MarketWatch
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips' leadership in precision diagnostics in neurology - Finviz
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology - Sahm
Philips brings AI into the procedure room to assist doctors during heart valve repair - Finviz
The Best Healthcare Stocks to Buy - Morningstar
Sony Group Corp. ADR rises Tuesday, outperforms market - MarketWatch
Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA - Sahm
Philips Ultrasound Devices Deemed Adulterated Over Manufacturing And Oversight Lapses - Sahm
Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI - Sahm
ETFs Investing in Koninklijke Philips N.V. Sponsored ADR Stocks - TradingView
Cash per share of Koninklijke Philips N.V. Sponsored ADR – LSE:0A2M - TradingView
Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide - Sahm
Citi Keeps Their Hold Rating on Koninklijke Philips N.V. (0LNG) - The Globe and Mail
Barclays Remains a Buy on Koninklijke Philips N.V. (0LNG) - The Globe and Mail
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Philips Reports Q2 2025 Growth and Raises Outlook - The Globe and Mail
Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces - Sahm
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Stock listing information - Philips
10 Undervalued Stocks That Crushed Q1 Earnings - Morningstar Canada
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Sony Group Corp. ADR outperforms market despite losses on the day - MarketWatch
Sony Group Corp. ADR rises Thursday, outperforms market - MarketWatch
Finanzdaten der Koninklijke Philips N V Adr-Aktie (PHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):